Marshall Wace’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-275,284
| Closed | -$1.13M | – | 3866 |
|
|
2022
Q1 | $1.13M | Buy |
+275,284
| New | +$1.13M | ﹤0.01% | 1820 |
|
|
2021
Q1 | – | Sell |
-95,522
| Closed | -$381K | – | 2773 |
|
|
2020
Q4 | $381K | Sell |
95,522
-138,205
| -59% | -$551K | ﹤0.01% | 1458 |
|
|
2020
Q3 | $631K | Sell |
233,727
-260,094
| -53% | -$702K | ﹤0.01% | 1134 |
|
|
2020
Q2 | $1.36M | Sell |
493,821
-331,240
| -40% | -$910K | 0.01% | 890 |
|
|
2020
Q1 | $1.95M | Buy |
825,061
+136,440
| +20% | +$322K | 0.02% | 636 |
|
|
2019
Q4 | $3.24M | Buy |
688,621
+334,189
| +94% | +$1.57M | 0.02% | 633 |
|
|
2019
Q3 | $1.18M | Sell |
354,432
-734,225
| -67% | -$2.45M | 0.01% | 864 |
|
|
2019
Q2 | $3.58M | Sell |
1,088,657
-220
| -0% | -$724 | 0.03% | 576 |
|
|
2019
Q1 | $3.3M | Buy |
1,088,877
+220
| +0% | +$667 | 0.03% | 585 |
|
|
2018
Q4 | $2.96M | Buy |
1,088,657
+1,037,693
| +2,036% | +$2.82M | 0.03% | 622 |
|
|
2018
Q3 | $171K | Buy |
+50,964
| New | +$171K | ﹤0.01% | 1078 |
|